TY - JOUR
T1 - Molecular basis for acceptor substrate specificity of the human beta1,3-glucuronosyltransferases GlcAT-I and GlcAT-P involved in glycosaminoglycan and HNK-1 carbohydrate epitope biosynthesis, respectively
AU - Fondeur-Gelinotte, Magali
AU - Lattard, Virginie
AU - Gulberti, Sandrine
AU - Oriol, Rafael
AU - Mulliert, Guillermo
AU - Coughtrie, Michael W. H.
AU - Magdalou, Jacques
AU - Netter, Patrick
AU - Ouzzine, Mohamed
AU - Fournel-Gigleux, Sylvie
N1 - dc.publisher: Oxford University Press
dc.description.sponsorship: Fonds National pour la Science (ACI no. 0693, Biologie Cellulaire, Moléculaire et Structurale, BMCS152 2004)
Agence Nationale pour la Recherche (GT-GAG NT05-3_42251/2005)
IT2B CNRS-INSERM regional program
PRO-A INSERM regional program
PHRC regional program
CNRS (GDR 2590)
Association pour la Recherche sur le Cancer (ARC, 3611)
“Contrat d'Interface International” between INSERM (S.F.-G.) and the University of Dundee, UK (M.W.H.C.)
PY - 2007/8
Y1 - 2007/8
N2 - The human ß1,3-glucuronosyltransferases galactose-ß1,3-glucuronosyltransferase I (GlcAT-I) and galactose-ß1,3-glucuronosyltransferase P (GlcAT-P) are key enzymes involved in proteoglycan and HNK-1 carbohydrate epitope synthesis, respectively. Analysis of their acceptor specificity revealed that GlcAT-I was selective toward Galß1,3Gal (referred to as Gal2-Gal1), whereas GlcAT-P presented a broader profile. To understand the molecular basis of acceptor substrate recognition, we constructed mutants and chimeric enzymes based on multiple sequence alignment and structural information. The drastic effect of mutations of Glu227, Arg247, Asp252, and Glu281 on GlcAT-I activity indicated a key role for the hydrogen bond network formed by these four conserved residues in dictating Gal2 binding. Investigation of GlcAT-I determinants governing Gal1 recognition showed that Trp243 could not be replaced by its counterpart Phe in GlcAT-P. This result combined with molecular modeling provided evidence for the importance of stacking interactions with Trp at position 243 in the selectivity of GlcAT-I toward Galß1,3Gal. Mutation of Gln318 predicted to be hydrogen-bonded to 6-hydroxyl of Gal1 had little effect on GlcAT-I activity, reinforcing the role of Trp243 in Gal1 binding. Substitution of Phe245 in GlcAT-P by Ala selectively abolished Galß1,3Gal activity, also highlighting the importance of an aromatic residue at this position in defining the specificity of GlcAT-P. Finally, substituting Phe245, Val320, or Asn321 in GlcAT-P predicted to interact with N-acetylglucosamine (GlcNAc), by their counterpart in GlcAT-I, moderately affected the activity toward the reference substrate of GlcAT-P, N-acetyllactosamine, indicating that its active site tolerates amino acid substitutions, an observation that parallels its promiscuous substrate profile. Taken together, the data clearly define key residues governing the specificity of ß1,3-glucuronosyltransferases.
AB - The human ß1,3-glucuronosyltransferases galactose-ß1,3-glucuronosyltransferase I (GlcAT-I) and galactose-ß1,3-glucuronosyltransferase P (GlcAT-P) are key enzymes involved in proteoglycan and HNK-1 carbohydrate epitope synthesis, respectively. Analysis of their acceptor specificity revealed that GlcAT-I was selective toward Galß1,3Gal (referred to as Gal2-Gal1), whereas GlcAT-P presented a broader profile. To understand the molecular basis of acceptor substrate recognition, we constructed mutants and chimeric enzymes based on multiple sequence alignment and structural information. The drastic effect of mutations of Glu227, Arg247, Asp252, and Glu281 on GlcAT-I activity indicated a key role for the hydrogen bond network formed by these four conserved residues in dictating Gal2 binding. Investigation of GlcAT-I determinants governing Gal1 recognition showed that Trp243 could not be replaced by its counterpart Phe in GlcAT-P. This result combined with molecular modeling provided evidence for the importance of stacking interactions with Trp at position 243 in the selectivity of GlcAT-I toward Galß1,3Gal. Mutation of Gln318 predicted to be hydrogen-bonded to 6-hydroxyl of Gal1 had little effect on GlcAT-I activity, reinforcing the role of Trp243 in Gal1 binding. Substitution of Phe245 in GlcAT-P by Ala selectively abolished Galß1,3Gal activity, also highlighting the importance of an aromatic residue at this position in defining the specificity of GlcAT-P. Finally, substituting Phe245, Val320, or Asn321 in GlcAT-P predicted to interact with N-acetylglucosamine (GlcNAc), by their counterpart in GlcAT-I, moderately affected the activity toward the reference substrate of GlcAT-P, N-acetyllactosamine, indicating that its active site tolerates amino acid substitutions, an observation that parallels its promiscuous substrate profile. Taken together, the data clearly define key residues governing the specificity of ß1,3-glucuronosyltransferases.
KW - β1,3-glucuronosyltransferases
KW - Acceptor substrate specificity
KW - Glycosaminoglycans
KW - Kinetics
KW - Site-directed mutagenesis
U2 - 10.1093/glycob/cwm055
DO - 10.1093/glycob/cwm055
M3 - Article
C2 - 17567734
SN - 0959-6658
VL - 17
SP - 857
EP - 867
JO - Glycobiology
JF - Glycobiology
IS - 8
ER -